Pharmaceutical firms eyes OTC drugs

Published: 2011-10-27 06:59:00

Updated: 2011-10-27 06:59:00

Domestic drug firms are seeking a breakthrough in their sluggish ethical business by entering more promising over-the-counter (OTC) market as they believe it will create more profits.

Chong Kun Dang Pharmaceutical and Samjin Pharmaceutical have stepped their marketing for their popular pain k...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK